IFNAR2 and COVID-19: Here, through an integrative approach including clinical and biomarker data evaluation, transcriptomic analysis of immune cells isolated from SARS-CoV-2 infected patients and in vitro functional characterization studies on peripheral blood mononuclear cells (PBMCs) of healthy subjects, we aimed to describe the immune pathways linking IFNAR2 with severe COVID-19.